Physician profile
Anu Vellanki
NPI 1477783165
$2,136.75
in general payments reported to CMS, 2019-2025
30 companies · $790 in 2025
The $790 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $28.26 · 2021: $18.59 · 2022: $314 · 2023: $443 · 2024: $424 · 2025: $790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,657.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $590.80 | 2022-2025 | |
| Amgen INC. | $277.62 | 2022-2025 | Repatha, Repatha |
| Pfizer INC. | $212.58 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $120.82 | 2019-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $113.87 | 2020-2024 | Xarelto |
| Abiomed | $73.96 | 2024-2025 | Impella |
| Actelion Pharmaceuticals US, INC. | $66.51 | 2023-2025 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.69 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.72 | 2024-2025 | Lifevest |
| Heartflow, INC. | $54.54 | 2023-2025 | Ffrct |
| Merck Sharp & Dohme LLC | $52.47 | 2022-2025 | Verquvo |
| Scpharmaceuticals INC. | $50.07 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $43.35 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.91 | 2025 | |
| Boston Scientific Corporation | $28.94 | 2025 | Watchman Flx |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $25.28 | 2025 | Sapien 3 Ultra Resilia |
| Exact Sciences Corporation | $23.84 | 2024 | Cologuard Collection Kit |
| Bridgebio Pharma, INC. | $23.31 | 2025 | Attruby |
| Esperion Therapeutics, INC. | $22.66 | 2023 | Nexletol |
| Lantheus Medical Imaging, INC. | $22.64 | 2024 | |
| Sanofi-Aventis U.S. LLC | $21.06 | 2024 | |
| Abbott Laboratories | $18.59 | 2021 | |
| Amarin Pharma, INC. | $17.96 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $17.95 | 2023 | Evkeeza, Praluent |
| Janssen Scientific Affairs, LLC | $16.51 | 2024 | Xarelto |
| Ionis Pharmaceuticals, INC. | $16.07 | 2025 | Tryngolza |
| Inspire Medical Systems, INC. | $15.97 | 2025 | Inspire |
| Novo Nordisk INC | $14.99 | 2025 | Wegovy |
| Irhythm Technologies, INC. | $14.28 | 2023 | Zio Xt Patch |
| Philips North America LLC | $13.79 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anu Vellanki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.